KalVista Pharmaceuticals, Inc.KalVista Pharmaceuticals, Inc.KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪555.84 M‬USD
−3.54USD
‪−126.64 M‬USD
0.00USD
‪28.67 M‬
Beta (1Y)
1.09
Employees (FY)
150
Change (1Y)
+32 +27.12%
Revenue / Employee (1Y)
0.00USD
Net income / Employee (1Y)
‪−844.29 K‬USD

About KalVista Pharmaceuticals, Inc.


CEO
Benjamin L. Palleiko
Headquarters
Cambridge
Founded
2004
FIGI
BBG0026ZG5B0
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of KALV is 10.67 USD — it has decreased by −2.80% in the past 24 hours. Watch KalVista Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange KalVista Pharmaceuticals, Inc. stocks are traded under the ticker KALV.
KALV stock has fallen by −1.86% compared to the previous week, the month change is a 1.28% rise, over the last year KalVista Pharmaceuticals, Inc. has showed a 30.12% increase.
We've gathered analysts' opinions on KalVista Pharmaceuticals, Inc. future price: according to them, KALV price has a max estimate of 39.00 USD and a min estimate of 18.00 USD. Watch KALV chart and read a more detailed KalVista Pharmaceuticals, Inc. stock forecast: see what analysts think of KalVista Pharmaceuticals, Inc. and suggest that you do with its stocks.
KALV reached its all-time high on Jun 8, 2015 with the price of 129.16 USD, and its all-time low was 4.12 USD and was reached on Oct 19, 2022. View more price dynamics on KALV chart.
See other stocks reaching their highest and lowest prices.
KALV stock is 6.00% volatile and has beta coefficient of 1.09. Track KalVista Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is KalVista Pharmaceuticals, Inc. there?
Today KalVista Pharmaceuticals, Inc. has the market capitalization of ‪540.25 M‬, it has decreased by −1.89% over the last week.
Yes, you can track KalVista Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
KalVista Pharmaceuticals, Inc. is going to release the next earnings report on Dec 5, 2024. Keep track of upcoming events with our Earnings Calendar.
KALV earnings for the last quarter are −0.87 USD per share, whereas the estimation was −0.92 USD resulting in a 4.92% surprise. The estimated earnings for the next quarter are −0.93 USD per share. See more details about KalVista Pharmaceuticals, Inc. earnings.
KalVista Pharmaceuticals, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
KALV net income for the last quarter is ‪−40.44 M‬ USD, while the quarter before that showed ‪−44.65 M‬ USD of net income which accounts for 9.42% change. Track more KalVista Pharmaceuticals, Inc. financial stats to get the full picture.
No, KALV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2024, the company has 150.00 employees. See our rating of the largest employees — is KalVista Pharmaceuticals, Inc. on this list?
Like other stocks, KALV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KalVista Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KalVista Pharmaceuticals, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KalVista Pharmaceuticals, Inc. stock shows the sell signal. See more of KalVista Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.